Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies - PubMed (original) (raw)
. 1999 Dec 10;53(9):2003-9.
doi: 10.1212/wnl.53.9.2003.
Affiliations
- PMID: 10599772
- DOI: 10.1212/wnl.53.9.2003
Clinicopathologic correlates in temporal cortex in dementia with Lewy bodies
T Gómez-Isla et al. Neurology. 1999.
Abstract
Objective: To address the relationship between dementia and neuropathologic findings in dementia with Lewy bodies (DLB) in comparison with AD.
Methods: We evaluated the clinical presentation of autopsy-confirmed DLB in comparison with AD according to new Consortium on DLB criteria and compared the two conditions using quantitative neuropathologic techniques. This clinicopathologic series included 81 individuals with AD, 20 with DLB (7 "pure" DLB and 13 "DLB/AD"), and 33 controls. We counted number of LB, neurons, senile plaques (SP), and neurofibrillary tangles (NFT) in a high order association cortex, the superior temporal sulcus (STS), using stereologic counting techniques.
Results: The sensitivity and specificity of Consortium on DLB clinical criteria in this series for dementia, hallucinations, and parkinsonism are 53% and 83%, respectively, at the patient's initial visit and 90% and 68%, respectively, if data from all clinic visits are considered. In pathologically confirmed DLB brains, LB formation in an association cortical area does not significantly correlate with duration of illness, neuronal loss, or concomitant AD-type pathology. Unlike AD, there is no significant neuronal loss in the STS of DLB brains unless there is concomitant AD pathology (neuritic SP and NFT).
Conclusions: The evaluation of new Consortium on DLB criteria in this series highlights their utility and applicability in clinicopathologic studies but suggests that sensitivity and specificity, especially at the time of the first clinical evaluation, are modest. The lack of a relationship of LB formation to the amount of Alzheimer-type changes in this series suggests that DLB is a distinct pathology rather than a variant of AD.
Similar articles
- Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W, Iseki E, Kato M, Akatsu H, Kosaka K. Marui W, et al. Acta Neuropathol. 2004 Aug;108(2):121-8. doi: 10.1007/s00401-004-0869-4. Epub 2004 May 14. Acta Neuropathol. 2004. PMID: 15235805 - Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
Chai YL, Chong JR, Weng J, Howlett D, Halsey A, Lee JH, Attems J, Aarsland D, Francis PT, Chen CP, Lai MKP. Chai YL, et al. Brain Pathol. 2019 Jan;29(1):63-74. doi: 10.1111/bpa.12631. Epub 2018 Oct 17. Brain Pathol. 2019. PMID: 30051532 Free PMC article. - Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies.
Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. Merdes AR, et al. Neurology. 2003 May 27;60(10):1586-90. doi: 10.1212/01.wnl.0000065889.42856.f2. Neurology. 2003. PMID: 12771246 - Dementia with Lewy bodies.
McKeith IG, Burn DJ, Ballard CG, Collerton D, Jaros E, Morris CM, McLaren A, Perry EK, Perry R, Piggott MA, O'Brien JT. McKeith IG, et al. Semin Clin Neuropsychiatry. 2003 Jan;8(1):46-57. doi: 10.1053/scnp.2003.50006. Semin Clin Neuropsychiatry. 2003. PMID: 12567332 Review. - [Neuropathologic Aspects of Co-occurrence of Dementia with Lewy Bodies and Alzheimer's Disease].
Takao M. Takao M. Brain Nerve. 2018 Aug;70(8):905-913. doi: 10.11477/mf.1416201099. Brain Nerve. 2018. PMID: 30082500 Review. Japanese.
Cited by
- Brain Atrophy of Secondary REM-Sleep Behavior Disorder in Neurodegenerative Disease.
Kim HJ, Im HK, Kim J, Han JY, de Leon M, Deshpande A, Moon WJ. Kim HJ, et al. J Alzheimers Dis. 2016 Apr 5;52(3):1101-9. doi: 10.3233/JAD-151197. J Alzheimers Dis. 2016. PMID: 27060938 Free PMC article. - Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.
Hatton C, Reeve A, Lax NZ, Blain A, Ng YS, El-Agnaf O, Attems J, Taylor JP, Turnbull D, Erskine D. Hatton C, et al. Acta Neuropathol Commun. 2020 Jul 9;8(1):103. doi: 10.1186/s40478-020-00985-8. Acta Neuropathol Commun. 2020. PMID: 32646480 Free PMC article. - Magnetic resonance spectroscopy in Alzheimer's disease.
Graff-Radford J, Kantarci K. Graff-Radford J, et al. Neuropsychiatr Dis Treat. 2013;9:687-96. doi: 10.2147/NDT.S35440. Epub 2013 May 16. Neuropsychiatr Dis Treat. 2013. PMID: 23696705 Free PMC article. - Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.
Hsu YY, Du AT, Schuff N, Weiner MW. Hsu YY, et al. J Geriatr Psychiatry Neurol. 2001 Fall;14(3):145-66. doi: 10.1177/089198870101400308. J Geriatr Psychiatry Neurol. 2001. PMID: 11563438 Free PMC article. Review. - Lewy bodies and dementia.
Galasko D. Galasko D. Curr Neurol Neurosci Rep. 2001 Sep;1(5):435-41. doi: 10.1007/s11910-001-0103-x. Curr Neurol Neurosci Rep. 2001. PMID: 11898554 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical